Clinical Trials Browser

Completed × NETWORK × Ipilimumab × Clear all

NCT02046733 2024-11-08

STIMULI

Phase 2 Completed

222 enrolled 18 charts

Diabetes Mellitus, Insulin-Dependent, 12, Small Cell Lung Carcinoma

NCT02154490 2023-06-01

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

1,864 enrolled 12 charts

Recurrent Squamous Cell Lung Carcinoma